Evaluation	B:C0220825
of	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
anti-urolithiatic	O
activity	O
of	O
silver	O
nanoparticles	O
containing	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
.	O

Evaluation	O
of	O
in	O
vitro	O
and	O
in	B:C1515655
vivo	I:C1515655
anti-urolithiatic	O
activity	O
of	O
silver	O
nanoparticles	O
containing	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
.	O

Evaluation	O
of	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
anti-urolithiatic	O
activity	O
of	O
silver	B:C0037125
nanoparticles	O
containing	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
.	O

Evaluation	O
of	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
anti-urolithiatic	O
activity	O
of	O
silver	O
nanoparticles	O
containing	O
aqueous	O
leaf	B:C0242724
extract	O
of	O
Tragia	O
involucrata	I:C3762783
.	O

Evaluation	O
of	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
anti-urolithiatic	O
activity	O
of	O
silver	O
nanoparticles	O
containing	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	B:C3762783
involucrata	I:C3762783
.	O

The	O
present	O
investigation	B:C0220825
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
(	O
Tragia	O
involucrata	I:C3762783
)	O
and	O
its	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	O
,	O
flavonoid	O
,	O
terpenoid	O
and	O
sterol	O
contents	O
present	O
in	O
Tragia	O
involucrata	I:C3762783
.	O

The	O
present	O
investigation	O
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	B:C0242724
extract	O
of	O
Tragia	O
involucrata	I:C3762783
(	O
Tragia	O
involucrata	I:C3762783
)	O
and	O
its	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	O
,	O
flavonoid	O
,	O
terpenoid	O
and	O
sterol	O
contents	O
present	O
in	O
Tragia	O
involucrata	I:C3762783
.	O

The	O
present	O
investigation	O
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	B:C3762783
involucrata	I:C3762783
(	O
Tragia	O
involucrata	I:C3762783
)	O
and	O
its	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	O
,	O
flavonoid	O
,	O
terpenoid	O
and	O
sterol	O
contents	O
present	O
in	O
Tragia	O
involucrata	I:C3762783
.	O

The	O
present	O
investigation	O
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
(	O
Tragia	B:C3762783
involucrata	I:C3762783
)	O
and	O
its	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	O
,	O
flavonoid	O
,	O
terpenoid	O
and	O
sterol	O
contents	O
present	O
in	O
Tragia	O
involucrata	I:C3762783
.	O

The	O
present	O
investigation	O
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
(	O
Tragia	O
involucrata	I:C3762783
)	O
and	O
its	O
silver	B:C0037125
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	O
,	O
flavonoid	O
,	O
terpenoid	O
and	O
sterol	O
contents	O
present	O
in	O
Tragia	O
involucrata	I:C3762783
.	O

The	O
present	O
investigation	O
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
(	O
Tragia	O
involucrata	I:C3762783
)	O
and	O
its	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	B:C0070570
,	O
flavonoid	O
,	O
terpenoid	O
and	O
sterol	O
contents	O
present	O
in	O
Tragia	O
involucrata	I:C3762783
.	O

The	O
present	O
investigation	O
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
(	O
Tragia	O
involucrata	I:C3762783
)	O
and	O
its	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	O
,	O
flavonoid	B:C0596577
,	O
terpenoid	O
and	O
sterol	O
contents	O
present	O
in	O
Tragia	O
involucrata	I:C3762783
.	O

The	O
present	O
investigation	O
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
(	O
Tragia	O
involucrata	I:C3762783
)	O
and	O
its	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	O
,	O
flavonoid	O
,	O
terpenoid	B:C0039561
and	O
sterol	O
contents	O
present	O
in	O
Tragia	O
involucrata	I:C3762783
.	O

The	O
present	O
investigation	O
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
(	O
Tragia	O
involucrata	I:C3762783
)	O
and	O
its	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	O
,	O
flavonoid	O
,	O
terpenoid	O
and	O
sterol	B:C0038323
contents	O
present	O
in	O
Tragia	O
involucrata	I:C3762783
.	O

The	O
present	O
investigation	O
is	O
focused	O
on	O
exploring	O
the	O
anti-urolithiatic	O
potential	O
of	O
aqueous	O
leaf	O
extract	O
of	O
Tragia	O
involucrata	I:C3762783
(	O
Tragia	O
involucrata	I:C3762783
)	O
and	O
its	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
and	O
to	O
quantify	O
the	O
total	O
phenol	O
,	O
flavonoid	O
,	O
terpenoid	O
and	O
sterol	O
contents	O
present	O
in	O
Tragia	B:C3762783
involucrata	I:C3762783
.	O

Quantification	O
results	O
suggested	O
Tragia	B:C3762783
involucrata	I:C3762783
to	O
be	O
a	O
rich	O
source	I:C0449416
of	O
phenol	O
,	O
flavonoid	O
and	O
terpenoid	O
and	O
less	O
of	O
sterol	O
content	O
.	O

Quantification	O
results	O
suggested	O
Tragia	O
involucrata	I:C3762783
to	O
be	O
a	O
rich	B:C0449416
source	I:C0449416
of	O
phenol	O
,	O
flavonoid	O
and	O
terpenoid	O
and	O
less	O
of	O
sterol	O
content	O
.	O

Quantification	O
results	O
suggested	O
Tragia	O
involucrata	I:C3762783
to	O
be	O
a	O
rich	O
source	I:C0449416
of	O
phenol	B:C0070570
,	O
flavonoid	O
and	O
terpenoid	O
and	O
less	O
of	O
sterol	O
content	O
.	O

Quantification	O
results	O
suggested	O
Tragia	O
involucrata	I:C3762783
to	O
be	O
a	O
rich	O
source	I:C0449416
of	O
phenol	O
,	O
flavonoid	B:C0596577
and	O
terpenoid	O
and	O
less	O
of	O
sterol	O
content	O
.	O

Quantification	O
results	O
suggested	O
Tragia	O
involucrata	I:C3762783
to	O
be	O
a	O
rich	O
source	I:C0449416
of	O
phenol	O
,	O
flavonoid	O
and	O
terpenoid	B:C0039561
and	O
less	O
of	O
sterol	O
content	O
.	O

Quantification	O
results	O
suggested	O
Tragia	O
involucrata	I:C3762783
to	O
be	O
a	O
rich	O
source	I:C0449416
of	O
phenol	O
,	O
flavonoid	O
and	O
terpenoid	O
and	O
less	O
of	O
sterol	B:C0038323
content	O
.	O

The	O
AgNPs	O
were	O
synthesized	O
by	O
a	O
simple	O
green	O
method	O
using	O
aqueous	O
extract	O
of	O
T.	B:C3762783
involucrata	I:C3762783
.	O

The	O
formation	O
of	O
AgNPs	O
was	O
confirmed	O
through	O
UV	O
spectroscopy	O
,	O
particle	O
size	O
analysis	B:C0936012
,	O
zeta	O
potential	O
,	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
and	O
transmission	O
electron	I:C0678118
microscopy	I:C0678118
.	O

The	O
formation	O
of	O
AgNPs	O
was	O
confirmed	O
through	O
UV	O
spectroscopy	O
,	O
particle	O
size	O
analysis	O
,	O
zeta	O
potential	O
,	O
X	B:C0043301
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
and	O
transmission	O
electron	I:C0678118
microscopy	I:C0678118
.	O

The	O
formation	O
of	O
AgNPs	O
was	O
confirmed	O
through	O
UV	O
spectroscopy	O
,	O
particle	O
size	O
analysis	O
,	O
zeta	O
potential	O
,	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
and	O
transmission	B:C0678118
electron	I:C0678118
microscopy	I:C0678118
.	O

The	O
in	O
vitro	O
struvite	B:C0075338
growth	O
inhibitory	O
activity	O
of	O
the	O
extract	O
was	O
performed	O
using	O
a	O
single	O
gel	I:C0025663
diffusion	I:C0025663
method	I:C0025663
.	O

The	O
in	O
vitro	O
struvite	O
growth	O
inhibitory	O
activity	O
of	O
the	O
extract	O
was	O
performed	O
using	O
a	O
single	B:C0025663
gel	I:C0025663
diffusion	I:C0025663
method	I:C0025663
.	O

Samples	O
incorporated	O
with	O
higher	O
concentration	O
of	O
2	O
%	O
Tragia	B:C3762783
involucrata	I:C3762783
and	O
AgNPs	O
(	O
200	O
μg	O
m	O
L	O
(	O
-	O
1	O
)	O
)	O
exhibited	O
potent	O
crystal	O
growth	O
inhibitory	O
activity	O
which	O
was	O
further	O
supported	O
by	O
the	O
dissolution	O
of	O
crystals	O
in	O
gel	O
medium	O
.	O

Samples	O
incorporated	O
with	O
higher	O
concentration	O
of	O
2	O
%	O
Tragia	O
involucrata	I:C3762783
and	O
AgNPs	O
(	O
200	O
μg	O
m	O
L	O
(	O
-	O
1	O
)	O
)	O
exhibited	O
potent	O
crystal	O
growth	O
inhibitory	O
activity	O
which	O
was	O
further	O
supported	O
by	O
the	O
dissolution	B:C1285147
of	O
crystals	O
in	O
gel	O
medium	O
.	O

Samples	O
incorporated	O
with	O
higher	O
concentration	O
of	O
2	O
%	O
Tragia	O
involucrata	I:C3762783
and	O
AgNPs	O
(	O
200	O
μg	O
m	O
L	O
(	O
-	O
1	O
)	O
)	O
exhibited	O
potent	O
crystal	O
growth	O
inhibitory	O
activity	O
which	O
was	O
further	O
supported	O
by	O
the	O
dissolution	O
of	O
crystals	B:C1378554
in	O
gel	O
medium	O
.	O

Samples	O
incorporated	O
with	O
higher	O
concentration	O
of	O
2	O
%	O
Tragia	O
involucrata	I:C3762783
and	O
AgNPs	O
(	O
200	O
μg	O
m	O
L	O
(	O
-	O
1	O
)	O
)	O
exhibited	O
potent	O
crystal	O
growth	O
inhibitory	O
activity	O
which	O
was	O
further	O
supported	O
by	O
the	O
dissolution	O
of	O
crystals	O
in	O
gel	B:C0017243
medium	O
.	O

Calcium	O
oxalate	O
stone	O
formation	O
was	O
induced	O
in	O
rats	B:C0034721
by	O
the	O
oral	O
administration	I:C0001563
of	O
ethylene	O
glycol	I:C0015083
in	O
water	O
.	O

Calcium	O
oxalate	O
stone	O
formation	O
was	O
induced	O
in	O
rats	O
by	O
the	O
oral	B:C0001563
administration	I:C0001563
of	O
ethylene	O
glycol	I:C0015083
in	O
water	O
.	O

Calcium	O
oxalate	O
stone	O
formation	O
was	O
induced	O
in	O
rats	O
by	O
the	O
oral	O
administration	I:C0001563
of	O
ethylene	B:C0015083
glycol	I:C0015083
in	O
water	O
.	O

Calcium	O
oxalate	O
stone	O
formation	O
was	O
induced	O
in	O
rats	O
by	O
the	O
oral	O
administration	I:C0001563
of	O
ethylene	O
glycol	I:C0015083
in	O
water	B:C0043047
.	O

Stone	B:C0006736
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	O
and	O
phosphorous	O
in	O
the	O
urine	O
and	O
accumulation	O
of	O
nitrogenous	O
substances	I:C0443444
like	O
urea	O
,	O
creatinine	O
in	O
renal	O
tissues	I:C1514845
and	O
blood	O
.	O

Stone	O
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	B:C0006675
and	O
phosphorous	O
in	O
the	O
urine	O
and	O
accumulation	O
of	O
nitrogenous	O
substances	I:C0443444
like	O
urea	O
,	O
creatinine	O
in	O
renal	O
tissues	I:C1514845
and	O
blood	O
.	O

Stone	O
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	O
and	O
phosphorous	B:C0031705
in	O
the	O
urine	O
and	O
accumulation	O
of	O
nitrogenous	O
substances	I:C0443444
like	O
urea	O
,	O
creatinine	O
in	O
renal	O
tissues	I:C1514845
and	O
blood	O
.	O

Stone	O
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	O
and	O
phosphorous	O
in	O
the	O
urine	B:C0042036
and	O
accumulation	O
of	O
nitrogenous	O
substances	I:C0443444
like	O
urea	O
,	O
creatinine	O
in	O
renal	O
tissues	I:C1514845
and	O
blood	O
.	O

Stone	O
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	O
and	O
phosphorous	O
in	O
the	O
urine	O
and	O
accumulation	B:C4055506
of	O
nitrogenous	O
substances	I:C0443444
like	O
urea	O
,	O
creatinine	O
in	O
renal	O
tissues	I:C1514845
and	O
blood	O
.	O

Stone	O
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	O
and	O
phosphorous	O
in	O
the	O
urine	O
and	O
accumulation	O
of	O
nitrogenous	B:C0443444
substances	I:C0443444
like	O
urea	O
,	O
creatinine	O
in	O
renal	O
tissues	I:C1514845
and	O
blood	O
.	O

Stone	O
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	O
and	O
phosphorous	O
in	O
the	O
urine	O
and	O
accumulation	O
of	O
nitrogenous	O
substances	I:C0443444
like	O
urea	B:C0041942
,	O
creatinine	O
in	O
renal	O
tissues	I:C1514845
and	O
blood	O
.	O

Stone	O
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	O
and	O
phosphorous	O
in	O
the	O
urine	O
and	O
accumulation	O
of	O
nitrogenous	O
substances	I:C0443444
like	O
urea	O
,	O
creatinine	B:C0010294
in	O
renal	O
tissues	I:C1514845
and	O
blood	O
.	O

Stone	O
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	O
and	O
phosphorous	O
in	O
the	O
urine	O
and	O
accumulation	O
of	O
nitrogenous	O
substances	I:C0443444
like	O
urea	O
,	O
creatinine	O
in	O
renal	B:C1514845
tissues	I:C1514845
and	O
blood	O
.	O

Stone	O
formation	O
was	O
assessed	O
by	O
increase	O
in	O
the	O
levels	O
of	O
calcium	O
and	O
phosphorous	O
in	O
the	O
urine	O
and	O
accumulation	O
of	O
nitrogenous	O
substances	I:C0443444
like	O
urea	O
,	O
creatinine	O
in	O
renal	O
tissues	I:C1514845
and	O
blood	B:C0005767
.	O

Prophylactic	B:C0199176
treatment	I:C0199176
with	O
Tragia	O
involucrata	I:C3762783
and	O
AgNPs	O
showed	O
significant	O
anti-urolithiatic	O
activity	O
with	O
normalization	O
of	O
the	O
mineral	O
contents	O
of	O
the	O
urine	O
and	O
serum	O
samples	I:C1550100
.	O

Prophylactic	O
treatment	I:C0199176
with	O
Tragia	B:C3762783
involucrata	I:C3762783
and	O
AgNPs	O
showed	O
significant	O
anti-urolithiatic	O
activity	O
with	O
normalization	O
of	O
the	O
mineral	O
contents	O
of	O
the	O
urine	O
and	O
serum	O
samples	I:C1550100
.	O

Prophylactic	O
treatment	I:C0199176
with	O
Tragia	O
involucrata	I:C3762783
and	O
AgNPs	O
showed	O
significant	O
anti-urolithiatic	O
activity	O
with	O
normalization	B:C1882115
of	O
the	O
mineral	O
contents	O
of	O
the	O
urine	O
and	O
serum	O
samples	I:C1550100
.	O

Prophylactic	O
treatment	I:C0199176
with	O
Tragia	O
involucrata	I:C3762783
and	O
AgNPs	O
showed	O
significant	O
anti-urolithiatic	O
activity	O
with	O
normalization	O
of	O
the	O
mineral	B:C0026162
contents	O
of	O
the	O
urine	O
and	O
serum	O
samples	I:C1550100
.	O

Prophylactic	O
treatment	I:C0199176
with	O
Tragia	O
involucrata	I:C3762783
and	O
AgNPs	O
showed	O
significant	O
anti-urolithiatic	O
activity	O
with	O
normalization	O
of	O
the	O
mineral	O
contents	O
of	O
the	O
urine	B:C0042036
and	O
serum	O
samples	I:C1550100
.	O

Prophylactic	O
treatment	I:C0199176
with	O
Tragia	O
involucrata	I:C3762783
and	O
AgNPs	O
showed	O
significant	O
anti-urolithiatic	O
activity	O
with	O
normalization	O
of	O
the	O
mineral	O
contents	O
of	O
the	O
urine	O
and	O
serum	B:C1550100
samples	I:C1550100
.	O

Histopathological	O
analysis	B:C0936012
of	O
the	O
kidney	O
of	O
Tragia	O
involucrata	I:C3762783
-	O
and	O
AgNP	O
-	O
treated	O
animals	O
showed	O
no	O
CaOx	O
deposits	O
and	O
a	O
normal	O
architecture	O
of	O
the	O
kidney	O
cells	I:C0553257
.	O

Histopathological	O
analysis	O
of	O
the	O
kidney	B:C0022646
of	O
Tragia	O
involucrata	I:C3762783
-	O
and	O
AgNP	O
-	O
treated	O
animals	O
showed	O
no	O
CaOx	O
deposits	O
and	O
a	O
normal	O
architecture	O
of	O
the	O
kidney	O
cells	I:C0553257
.	O

Histopathological	O
analysis	O
of	O
the	O
kidney	O
of	O
Tragia	B:C3762783
involucrata	I:C3762783
-	O
and	O
AgNP	O
-	O
treated	O
animals	O
showed	O
no	O
CaOx	O
deposits	O
and	O
a	O
normal	O
architecture	O
of	O
the	O
kidney	O
cells	I:C0553257
.	O

Histopathological	O
analysis	O
of	O
the	O
kidney	O
of	O
Tragia	O
involucrata	I:C3762783
-	O
and	O
AgNP	O
-	O
treated	O
animals	B:C0003062
showed	O
no	O
CaOx	O
deposits	O
and	O
a	O
normal	O
architecture	O
of	O
the	O
kidney	O
cells	I:C0553257
.	O

Histopathological	O
analysis	O
of	O
the	O
kidney	O
of	O
Tragia	O
involucrata	I:C3762783
-	O
and	O
AgNP	O
-	O
treated	O
animals	O
showed	O
no	O
CaOx	O
deposits	O
and	O
a	O
normal	O
architecture	O
of	O
the	O
kidney	B:C0553257
cells	I:C0553257
.	O

We	O
conclude	O
that	O
aqueous	O
extract	O
of	O
T.	B:C3762783
involucrata	I:C3762783
and	O
its	O
AgNPs	O
has	O
potential	O
for	O
the	O
treatment	O
of	O
patients	O
with	O
recurrent	O
stones	O
.	O

We	O
conclude	O
that	O
aqueous	O
extract	O
of	O
T.	O
involucrata	I:C3762783
and	O
its	O
AgNPs	O
has	O
potential	O
for	O
the	O
treatment	O
of	O
patients	O
with	O
recurrent	O
stones	B:C0006736
.	O

